Molina Healthcare stock drops 3.44% as Kidney Awareness Month tweet highlights kidney stone risk

Molina Healthcare stock drops 3.44% as Kidney Awareness Month tweet highlights kidney stone risk
Molina Healthcare drops 3.44% today

Molina Healthcare marked Kidney Awareness Month with tips to help reduce the risk of kidney stones.

The company advised staying hydrated with water and citrus drinks, and eating a balanced diet with fruits, vegetables, whole grains, and lean proteins.

Highlights

  • MOH trades well below major moving averages, confirming persistent downward pressure across all timeframes.
  • Multiple momentum indicators signal a firm bearish bias and oversold conditions, with sellers dominating the current trend.
  • Price is expected to consolidate within a $130–$140 range, with potential for further downside if support at $130 breaks.

MOH is currently trading at $134.03, well below its MA-20 ($144.12), MA-50 ($156.11), and MA-200 ($177.84), indicating sustained downward pressure across short-, medium-, and long-term trends. The Ichimoku Kijun at $145.74 acts as immediate resistance, while near-term support is seen at the MA-20 ($144.12) and key support emerges from the MA-50 ($156.11); immediate resistance is highlighted by the Kijun ($145.74) and key resistance by the MA-100 ($157.08).

Momentum indicators on D1 show a clear bearish bias: MACD gives a Sell signal and ADX at 19.97 suggests weak but prevailing downward momentum. RSI, Stoch RSI, and CCI all flag oversold conditions, highlighting a stretched downside but not yet a reversal. BBP at -1.87 confirms sellers dominate intraday, further backed by the AO’s Sell readout. MOH has fallen $5.38 (3.86%) from last week’s close of $139.41, now trading at the very bottom of its weekly range as volatility stands at 8.6%. The past week reflects a steady decline from the highs, and in today’s session, losses have accelerated with a drop of 3.44%, underlining ongoing selling pressure.

Looking ahead, the expected price range for the coming week is adjusted to $130–$140, which keeps the forecast realistic and centered around current levels despite the initial weekly estimates. With all D1 and W1 signals (MA, RSI, MACD, ADX) pointing to Sell, the probability of a price increase is very low (less than 20%), making a further decline much more likely. The baseline scenario is for MOH to consolidate in the $130–$140 corridor. A bullish scenario would require a breakout above the $145–$146 resistance zone, while a bearish break below $130 could target the 52-week low of $121.06. The price remains much closer to its yearly low than its $359.97 high, maintaining a decisively bearish tone for the short term.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.